Furthermore, it was encouraging that JAM-silenced xenografts scored lower for JAM-A expression than control xenografts; even if this was insufficient to translate into either gross (Figure S3) or microscopic (Figure S4) reductions in xenograft tumor size or invasive characteristics over a short experimental time course. The gene discussed is F11R; the disease is neoplasm.